Atlas Trials

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

Clinical trial NCT02881437 · COMPLETED

Trial details

NCT number
NCT02881437
Sponsor
University Hospital, Lille
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary Immunodeficiency
Start date
2016-11-11
Primary completion
2018-03-16
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.